Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ZOLL MEDICAL CORPa50139280ex99_1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

January 19, 2012

ZOLL MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)



Massachusetts

000-20225

04-2711626

(State or other jurisdiction of

incorporation)

(Commission File No.)

(IRS Employer

Identification No.)


269 Mill Road, Chelmsford, MA  01824

(Address of principal executive offices) (Zip Code)


Registrant’s telephone number, including area code:
(978) 421-9655

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


This Current Report on Form 8-K may contain forward-looking statements within the meaning of the federal securities laws.  Reliance should not be placed on forward-looking statements because they involve known and unknown risks and uncertainties which may cause the actual results, performance, and achievements of ZOLL Medical Corporation (the “Company”) to differ materially from the anticipated future results, performance and achievements that are expressed or implied by such forward-looking statements.  Additional information concerning these risks and uncertainties are contained in the Company’s press release filed as Exhibit 99.1 and in the section entitled “Risk Factors” of the Company’s Annual Report on Form 10-K filed on November 23, 2011, and in the Company’s other public filings.  The Company disclaims any obligation to update any of the forward-looking statements contained herein to reflect future developments or events.

Item 2.02 Results of Operations and Financial Condition.

On January 19, 2012, ZOLL Medical Corporation issued a press release announcing its financial and operational results for the fiscal quarter ended January 1, 2012.  A copy of this press release is furnished herewith as Exhibit 99.1 to this report.

The information in this report, including the Exhibit attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

  (d) Exhibits.

Exhibit No.

Title

 
99.1 Press release issued by ZOLL Medical Corporation on January 19, 2012, announcing its financial and operational results for the fiscal quarter and year ended January 1, 2012, furnished herewith.

SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ZOLL MEDICAL CORPORATION

 

Date: January 19, 2012 By:

/s/ Richard A. Packer

Richard A. Packer

Chief Executive Officer